Aberrant Cytokine Activity in the Host Immune Response to COVID-19 Leads to Cytokine Release Syndrome
White Paper Jul 28, 2020

Since the first cases of COVID-19 were identified in December 2019, the disease has spread across the world, claiming over half a million lives and affecting millions of others. Medical reports emerging from the pandemic illustrate a broad range of patient symptoms due to the host immune response, with evidence increasingly suggesting that cytokine release syndrome (CRS) may be responsible for the more severe complications of COVID-19.
Download this article to discover why the potential link between CRS and COVID-19-related deaths warrants further investigation, with details on:
- The mechanisms underlying CRS
- Supporting studies
- The tools used to examine the role of CRS
Related White Papers
Single-cell sequencing is quickly becoming a standard tool in biological research due to the scale and depth of insight it provides across diverse cell populations. The pharmaceutical industry is exploiting single-cell approaches to identify novel therapeutic targets and accelerate promising assets through development.
READ MOREThe rapid and cost-effective production of conventional monoclonal antibodies (mAbs) for clinical trials has contributed toward their wide adoption. As the number of next-generation antibody-based candidates with modified or absent Fc domains increases, biomanufacturers face a need to establish alternative affinity purification technologies.
READ MOREOver the past two decades, monoclonal antibodies (mAbs) have been one of the most dominant segments of the biotherapeutics market. Ensuring mAbs’ safety and efficacy is vital but is made complicated by the fact that antibodies can have a tendency to aggregate during production, decreasing efficacy and increasing the risk of immunogenicity.
READ MORELike what you just read? You can find similar content on the communities below.
Cell ScienceTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE